For patients with alcohol-related hepatocellular carcinoma (HCC), survival rates are poorer than for patients with HCC that is not alcohol related, primarily because they are diagnosed with late-stage disease, according to results from a new study. The study was published online March 28 in Cancer. Median overall survival was 9.7 months for patients with non-alcohol-related HCC compared to 5.7 months for patients with the alcohol-related HCC. However, when the authors reviewed each cancer stage individually, survival was similar, and the prognostic role of alcohol consumption disappeared.
To read the full article, visit: Medscape